Previous Close | 271.10 |
Open | 272.23 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1000 |
Day's Range | 267.25 - 272.09 |
52 Week Range | 182.09 - 281.70 |
Volume | |
Avg. Volume | 3,039,622 |
Market Cap | 193.43B |
Beta (5Y Monthly) | 0.86 |
PE Ratio (TTM) | 49.23 |
EPS (TTM) | 5.44 |
Earnings Date | Oct 22, 2024 - Oct 28, 2024 |
Forward Dividend & Yield | 1.08 (0.40%) |
Ex-Dividend Date | Jun 28, 2024 |
1y Target Est | 284.85 |
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Danaher (DHR) benefits from strength in the clinical diagnostics business, Abcam buyout and pro-investor policies. However, softness in its Instrument unit is concerning.
We recently published a list of Jim Cramer is Talking About These 10 Stocks Amid Global Selloff. Since Danaher Corporation (NYSE:DHR) ranks 6th on the list, it deserves a deeper look. Jim Cramer in his latest program on CNBC talked about the brutal market selloff of Monday and said days like these could make you “cry […]